Cargando…
Improved Natural Killer cell activity and retained anti-tumor CD8(+) T cell responses contribute to the induction of a pathological complete response in HER2-positive breast cancer patients undergoing neoadjuvant chemotherapy
BACKGROUND: Locally advanced HER2-overexpressing breast cancer (BC) patients achieve a high rate of pathological complete responses (pCR) after neoadjuvant chemotherapy (NC). The apparently unaltered immune proficiency of these patients together with the immune-modulating activities of NC drugs sugg...
Autores principales: | Muraro, E, Comaro, E, Talamini, R, Turchet, E, Miolo, G, Scalone, S, Militello, L, Lombardi, D, Spazzapan, S, Perin, T, Massarut, S, Crivellari, D, Dolcetti, Riccardo, Martorelli, D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4483222/ https://www.ncbi.nlm.nih.gov/pubmed/26116238 http://dx.doi.org/10.1186/s12967-015-0567-0 |
Ejemplares similares
-
Anthracycline-free neoadjuvant therapy induces pathological complete responses by exploiting immune proficiency in HER2+ breast cancer patients
por: Miolo, Gianmaria, et al.
Publicado: (2014) -
A different immunologic profile characterizes patients with HER-2-overexpressing and HER-2-negative locally advanced breast cancer: implications for immune-based therapies
por: Muraro, Elena, et al.
Publicado: (2011) -
KIR-HLA Functional Repertoire Influences Trastuzumab Efficiency in Patients With HER2-Positive Breast Cancer
por: Muraro, Elena, et al.
Publicado: (2022) -
Pharmacometabolomics study identifies circulating spermidine and tryptophan as potential biomarkers associated with the complete pathological response to trastuzumab-paclitaxel neoadjuvant therapy in HER-2 positive breast cancer
por: Miolo, Gianmaria, et al.
Publicado: (2016) -
Epirubicin and docetaxel as neoadjuvant treatment of hormone receptor positive, HER-2 negative breast cancer: findings from two successive phase II studies
por: Tuzi, Alessandro, et al.
Publicado: (2013)